Trial Profile
A Multicentre, Randomised, Open Clinical Study to Compare the Efficacy and Safety of a Combination of Tacrolimus and Mycophenolate Mofetil Based Regimen With or Without Induction in Elderly Recipients Undergoing Kidney Transplantation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Apr 2022
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Basiliximab; Corticosteroids; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms SENIOR
- Sponsors Astellas Pharma
- 15 Nov 2009 Primary endpoint 'Creatinine clearance' has not been met.
- 15 Nov 2009 Results reported in Transplantation.
- 01 Jan 2008 Status change from in progress to completed.